Clinical Trial Update: Effect of Lithium and Divalproex in Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lithium and divalproex for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Divalproex (divalproex sodium)
• Lithium (Lithium carbonate)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED